Organon & Co | Omsättningstillgångar



Current Assets Ändra Datum
Adcock Ingram Holdings ZAR 4.89B 194.86M 2024-06
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Celltrion KRW 5.37T 121.47B 2024-09
Cspc Pharmaceutical CNY 21.89B 4.58B 2024-12
Dianthus Therapeutics USD 280.9M 6.58M 2024-12
Ecofibre AUD 37.37M 2.03M 2024-06
Gilead Sciences USD 19.17B 4.39B 2024-12
Glaxosmithkline GBP 17B 301M 2024-12
Kangmei Pharma CNY 7.01B 15.81M 2024-09
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 489.61M 51.17M 2024-12
Malin Corporation EUR 35.9M 100K 2024-06
Medical Developments International AUD 26.14M 4.89M 2024-06
Merck USD 38.78B 1.58B 2024-12
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Organon & Co USD 4.35B 408M 2024-12
Pharma Mar EUR 236.01M 14.24M 2025-03
Qiagen NV USD 1.96B 494.22M 2024-12
Sartorius EUR 2.16B 45.8M 2025-03
Sino Biopharmaceutical CNY 24.69B 536.67M 2024-12
Tilray USD 707.34M 18.54M 2024-11



Organon & Co Omsättningstillgångar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.